Исследование остаточной вирулентности и иммунизирующей способности посевных серий Mycobacterium bovis BCG-1
Levi Dt(Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care"), Ю И Обухов, Н. В. Александрова(Onze Lieve Vrouwziekenhuis Hospital)
Biological Products Prevention Diagnosis Treatment
January 1, 2017
Cited by 0
Related Papers
Whole-Genome Sequence of Mycobacterium bovis BCG-1 (Russia)
|Genome Announcements|2015|9
Sepsis in Latvia—Incidence, Outcomes, and Healthcare Utilization: A Retrospective, Observational Study
|Healthcare|2024|2
Specific Aspects of Tuberculin Products Standardisation
|Biological Products Prevention Diagnosis Treatment|2019|1
Using Shewhart charts to monitor quality characteristics of preventive vaccines for tuberculosis
|Biological Products Prevention Diagnosis Treatment|2023|1
A diagnostic dilemma: distinguishing a sulfasalazine induced DRESS hypersensitivity syndrome from a CD30 + lymphoma in a young patient
|International Journal of Emergency Medicine|2024|1